Last reviewed · How we verify

NCT06886100

Melanin Recurrence in Scalpel and LASER Gingival Depigmentation in Thin and Thick Phenotypes.

Completed NA Last updated 20 March 2025
What this trial tests

NA trial testing Diode laser in Melanin Hyperpigmentation in 30 participants. Completed in 18 December 2024.

Timeline
4 March 2024
Primary endpoint
18 December 2024
18 December 2024

Quick facts

Lead sponsorThamar University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment30
Start date4 March 2024
Primary completion18 December 2024
Estimated completion18 December 2024
Sites1 location across Yemen

Drugs / interventions tested

Conditions studied

Sponsor

Thamar University

Who can join

20 and older, any sex, with Melanin Hyperpigmentation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to compare melanin pigmentation recurrence, pain perception and wound healing between laser and scalpel surgeries in thin and thick gingival phenotypes.Thirty patients (60 sites) were included in this study. They had bilateral physiologic melanin hyperpigmentation in the upper anterior segment with severe grade II melanin hyperpigmentation. The patients were divided into two groups: each with fifteen patients with severe grade II melanin pigmentation, one with thin gingiva and another with thick gingiva. Melanin depigmentation was done in one side using scalpel no. 15 and other side with diode laser.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Diode laser

Trials testing the same drug.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06886100.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing